DURHAM, N.C. -- Engineers at Duke University have developed a way to manipulate, split and mix droplets of biological fluids by having them surf on acoustic waves in oil. The technology could form the basis of a small-scale, programmable, rewritable biomedical chip that is completely reusable for disparate purposes from on-site diagnostics to laboratory-based research.
The study appears on July 26 in the journal Nature Communications.
It is more likely that you have seen a habu snake in a bottle of local rice liquor Awamori, in Okinawa, than that you've spotted one slithering by the wayside. Even so, habus are very common in the Ryukyu islands of which Okinawa is a part. Okinawa is home to three species of habu; the Okinawan habu (Protobothrops flavoviridis), endemic to the Ryukyu islands, is highly venomous.
University of Manchester and Salford Royal NHS Trust scientists have developed a lamp which could treat chronic ulcers with light.
The Arthritis Research UK funded trial led by Dr Michael Hughes tested the therapy - which combines infrared, red and ultraviolet light - on finger ulcers caused by a condition called systemic sclerosis, where the immune system attacks the body's fingers and toes.
TORONTO, July 25, 2018 - Engaging patients in the redesign of health care services can lead to reduced hospital admissions and more efficient and effective health care, a study led by a St. Michael's Hospital researcher suggests.
In their study, Engaging Patients to Improve Quality of Care: A Systematic Review, published today in Implementation Science, lead authors Dr. Yvonne Bombard and Dr. G. Ross Baker concluded that active engagement of patients can inform education, tools, planning and policy, and enhance health care service delivery and governance.
People living with HIV in rural East African communities that hosted annual community health campaigns initiated antiretroviral therapy (ART) earlier and had higher levels of overall survival and viral suppression than communities receiving standard HIV care, according to study data presented today at a press conference at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam.
(Vienna, July 25, 2018) In order to move, a body needs a strong scaffold. This is not only true on a macroscopic level, where animals rely on skeletons to support their muscles. It is also true on a cellular level: the cytoskeleton composed of actin filaments is crucial for every active movement of a cell. By rearranging these filaments, cells can stretch and wander in every direction, squeeze into the smallest gaps or wrap themselves around an object.
Each issue of the journal Nature Electronics contains a column called "Reverse Engineering," which examines the development of an electronic device now in widespread use from the viewpoint of the main inventor. So far, it has featured creations such as the DRAM, DVD, CD, and Li-ion rechargeable battery. The July 2018 column tells the story of the IGZO thin film transistor (TFT) through the eyes of Professor Hideo Hosono of Tokyo Tech's Institute of Innovative Research (IIR), who is also director of the Materials Research Center for Element Strategy.
An international team of materials scientists from France, Russia and Kazakhstan found a way to boost the efficiency of organic solar cells several times. The new study, published in the Journal of Materials Chemistry A, has shown that ordered structures based on organic molecules can be used to produce solar power.
CHAMPAIGN, Ill. -- Many city drinking water systems add softening agents to keep plumbing free of pipe-clogging mineral buildup. According to new research, these additives may amplify the risk of pathogen release into drinking water by weakening the grip that bacteria - like those responsible for Legionnaires' disease - have on pipe interiors.
New-generation lung cancer drugs have been effective in a large number of patients, but within about a year, the patients tend to develop resistance to the therapy. Researchers at the Weizmann Institute of Science, in collaboration with physicians, have conducted a study in mice, in which they used existing drugs in a new combination to help crush potential resistance to the treatment. Their findings were published recently in the journal Clinical Cancer Research.